Ocular Toxicity From New Oncology Agents: Safety Review
Episode Summary
Wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, requiring early recognition, multidisciplinary coordination, and proactive monitoring to protect vision without compromising cancer control.